Thomas Stübig

JAK1/2 inhibition impairs T cell function <i>in vitro</i> and in patients with myeloproliferative neoplasms

Sowmya Parampalli Yajnanarayana, Thomas Stübig, Isabelle Cornez et al. · British Journal of Haematology · 2015 · 159 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Comparative diagnostic performance of 18F-FDG PET/CT versus whole-body MRI for determination of remission status in multiple myeloma after stem cell transplantation

Thorsten Derlin, Kersten Peldschus, Silvia Münster et al. · European Radiology · 2012 · 93 citations

Medicine, Nuclear Medicine, Oncology +17

CD34+-Selected Stem Cell Boost without Further Conditioning for Poor Graft Function after Allogeneic Stem Cell Transplantation in Patients with Hematological Malignancies

Evgeny Klyuchnikov, Jean El Cheikh, Andreas Sputtek et al. · Biology of Blood and Marrow Transplantation · 2013 · 93 citations · Full text

Medicine, Hematology, Cell Therapy +8

Postallograft lenalidomide induces strong NK cell–mediated antimyeloma activity and risk for T cell–mediated GvHD: Results from a phase I/II dose-finding study

Christine Wolschke, Thomas Stübig, Ute Hegenbart et al. · Experimental Hematology · 2012 · 90 citations

Medicine, Oncology, Pharmacology +12

Impact of High-Risk Cytogenetics and Achievement of Molecular Remission on Long-Term Freedom from Disease after Autologous–Allogeneic Tandem Transplantation in Patients with Multiple Myeloma

Nicolaus Kröger, Anita Badbaran, Tatjana Zabelina et al. · Biology of Blood and Marrow Transplantation · 2012 · 88 citations · Full text

Medicine, Oncology, Chemotherapy +16